S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
LON:CTEC

ConvaTec Group (CTEC) Share Forecast, Price & News

GBX 208.20
-0.40 (-0.19%)
(As of 06/5/2023 ET)
Compare
Today's Range
207.20
209
50-Day Range
202.80
229.07
52-Week Range
195.90
257.87
Volume
1.67 million shs
Average Volume
4.31 million shs
Market Capitalization
£4.27 billion
P/E Ratio
10,410.00
Dividend Yield
2.40%
Price Target
GBX 269

ConvaTec Group MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
29.2% Upside
GBX 269 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
£98.91 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.89 out of 5 stars


CTEC stock logo

About ConvaTec Group (LON:CTEC) Stock

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

Receive CTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

CTEC Stock News Headlines

Convatec Group PLC: Total Voting Rights
ConvaTec Group (LON:CTEC) PT Raised to GBX 300 at Barclays
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Convatec Group PLC: Result of AGM
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
2 cheap shares I’d buy as the FTSE 100 slides
Convatec Group PLC: Annual Report and Accounts 2022 and Notice of AGM
Convatec Group PLC: Results of 2022 AGM Update Statement
Convatec Group PLC: Scrip Dividend - Calculation Price
Chris Gent fined £80,000 for trying his best
What lies in store for the ConvaTec share price?
ConvaTec Group PLC CTEC
See More Headlines

CTEC Price History

CTEC Company Calendar

Last Earnings
2/28/2020
Ex-Dividend for 5/25 Dividend
4/06/2023
Dividend Payable
5/25/2023
Today
6/05/2023

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
10,142
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 269
High Stock Price Forecast
GBX 300
Low Stock Price Forecast
GBX 215
Forecasted Upside/Downside
+29.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
£62.90 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.07 billion
Cash Flow
GBX 12.24 per share
Book Value
GBX 79 per share

Miscellaneous

Outstanding Shares
2,050,000,000
Free Float
N/A
Market Cap
£4.27 billion
Optionable
Not Optionable
Beta
0.65

Key Executives

  • Mr. Karim Bitar (Age 58)
    CEO & Director
    Comp: $3.48M
  • Mr. Jonathan P. Mason (Age 59)
    Group CFO & Director
  • Mr. Donal Balfe
    Exec. VP and Chief of Quality & Operations
  • Dr. Divakar Ramakrishnan Ph.D.
    Exec. VP & Chief Technology Officer
  • Mr. Mark Reynolds
    Director of Investor Relations
  • Ms. Kate Postans
    VP of Investor Relations & Corp. Communications
  • Ms. Natalia Kozmina
    Exec. VP & Chief HR Officer
  • Mr. Christian Hoengaard
    Sr. VP & GM - USA
  • Ms. Kjersti Grimsrud Biotechnology (Age 62)
    M.Sc., Pres & COO of Infusion Care
  • Mr. Supratim Bose (Age 71)
    Pres & COO of Global Emerging Markets













CTEC Stock - Frequently Asked Questions

Should I buy or sell ConvaTec Group stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CTEC shares.
View CTEC analyst ratings
or view top-rated stocks.

What is ConvaTec Group's stock price forecast for 2023?

4 brokers have issued 12 month price targets for ConvaTec Group's stock. Their CTEC share price forecasts range from GBX 215 to GBX 300. On average, they predict the company's stock price to reach GBX 269 in the next year. This suggests a possible upside of 29.2% from the stock's current price.
View analysts price targets for CTEC
or view top-rated stocks among Wall Street analysts.

How have CTEC shares performed in 2023?

ConvaTec Group's stock was trading at GBX 232.60 on January 1st, 2023. Since then, CTEC stock has decreased by 10.5% and is now trading at GBX 208.20.
View the best growth stocks for 2023 here
.

How were ConvaTec Group's earnings last quarter?

ConvaTec Group PLC (LON:CTEC) posted its earnings results on Friday, February, 28th. The company reported $12.00 EPS for the quarter, missing the consensus estimate of $12.70 by $0.70. ConvaTec Group had a net margin of 3.04% and a trailing twelve-month return on equity of 3.81%.

How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group?

ConvaTec Group declared a dividend on Thursday, March 9th. Stockholders of record on Thursday, April 6th will be paid a dividend of GBX 0.04 per share on Thursday, May 25th. This represents a yield of 1.63%. The ex-dividend date is Thursday, April 6th. The official announcement can be accessed at this link.
Read our dividend analysis for CTEC
.

Is ConvaTec Group a good dividend stock?

ConvaTec Group (LON:CTEC) pays an annual dividend of GBX 5 per share and currently has a dividend yield of 2.42%. The dividend payout ratio is 25,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for CTEC.

What other stocks do shareholders of ConvaTec Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Oxford Biomedica (OXB), Bristol-Myers Squibb (BMY), Andalas Energy and Power (ADL), AFR.L (AFR), CBTX (CBTX), Genel Energy (GENL), Premier Oil (PMO) and Playtech (PTEC).

What is ConvaTec Group's stock symbol?

ConvaTec Group trades on the London Stock Exchange (LON) under the ticker symbol "CTEC."

How do I buy shares of ConvaTec Group?

Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is ConvaTec Group's stock price today?

One share of CTEC stock can currently be purchased for approximately GBX 208.20.

How much money does ConvaTec Group make?

ConvaTec Group (LON:CTEC) has a market capitalization of £4.27 billion and generates £2.07 billion in revenue each year. The company earns £62.90 million in net income (profit) each year or GBX 0.02 on an earnings per share basis.

How many employees does ConvaTec Group have?

The company employs 10,142 workers across the globe.

How can I contact ConvaTec Group?

ConvaTec Group's mailing address is 3 Forbury Place Floor 7, 23 Forbury Road, ICKENHAM, RG1 3JH, United Kingdom. The official website for the company is www.convatecgroup.com. The company can be reached via phone at 44 11 8952 8100.

This page (LON:CTEC) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -